tirzepatide chinese name Mounjaro Top Chinese Tirzepatide API GMP

With off-patent semaglutide and new oral brands emerging from 2026, pharma should leverage FMCG pricing expertise, invest in real-time tracking of patient persistence and switching behaviours, and target drivers of engagement and loyalty beyond price

Unnikrishnan, CEO and Chief of Endocrinology at Chellaram Diabetes Institute, Pune, said, Oral semaglutide has shown it can reduce the risk of major adverse cardiovascular events (MACE), regardless of whether participants were already using sodium-glucose cotransporter-2 inhibitors (SGLT2i)

The Acid Challenge: Delayed gastric emptying (how the drug works) can worsen acid reflux

Summary GLP-1 RAs offer a multifaceted therapeutic strategy in PD, targeting both central neurodegenerative processes and peripheral metabolic dysfunction